EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In silico identification and in vitro evaluation of MRPS30‐DT lncRNA and MRPS30 gene expression in breast cancer

Nooshafarin Shirani iD, Roohallah Mahdi-Esferizi, Reza Eshraghi Samani, Shahram Tahmasebian, Hajar Yaghoobi iD

Cancer Reports · 2024

DOI: 10.1002/cnr2.2114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2024. Verfasst von Nooshafarin Shirani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Biochemistry Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran. Hauptthemen laut MEDLINE: Breast Neoplasms, Computational Biology, Computer Simulation, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shahrekord University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

It has been reported that long non‐coding RNAs (lncRNAs) can play important roles in a variety of biological processes and cancer regulatory networks, including breast cancer.

Aims

This study aimed to identify a novel upregulated lncRNA in breast cancer and its associated gene using bioinformatics analysis, and then evaluate their potential roles in breast cancer. Methods and Results Extensive in silico studies were performed using various bioinformatics databases and tools to identify a potential upregulated breast cancer‐associated lncRNA and its co‐expressed gene, and to predict their potential roles, functions, and interactions. The expression level of MRPS30‐DT lncRNA and MRPS30 was assessed in both BC tissues and cell lines using qRT‐PCR technology. MRPS30‐DT lncRNA and MRPS30 were selected as target genes using bioinformatics analysis. We found that MRPS30‐DT and MRPS30 were significantly overexpressed in BC tissues compared with normal tissues. Also, MRPS30 showed upregulation in all three BC cell lines compared with HDF. On the other hand, MRPS30‐DT significantly increased in MDA‐MB‐231 compared with HDF. While the expression of MRPS30‐DT was significantly dropped in the resistance cell line MCF/MX compared to HDF and MCF7. Moreover, bioinformatics analysis suggested that MRPS30‐DT and MRPS30 may play a potential role in BC through their involvement in some cancer signaling pathways and processes, as well as through their interaction with TFs, genes, miRNAs, and proteins related to carcinogenesis.

Conclusions

Overall, our findings showed the dysregulation of MRPS30‐DT lncRNA and MRPS30 may provide clues for exploring new therapeutic targets or molecular biomarkers in BC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsComputational BiologyComputer SimulationGene Expression Regulation, NeoplasticRNA, Long NoncodingFemaleHumansBiomarkers, TumorCell Line, TumorCell ProliferationGene Regulatory NetworksMCF-7 CellsUp-RegulationRibosomal ProteinsMitochondrial Proteins

Stichwörter der Autor:innen

MRPS30MRPS30‐DT lncRNAbioinformatics analysisbreast cancer

Substanzen

Biomarkers, TumorRNA, Long NoncodingMRPS30 protein, humanRibosomal ProteinsMitochondrial Proteins

Autor:innen und Institutionen

  • Clinical Biochemistry Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
  • Department of Medical Biotechnology, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran.
  • Department of General Surgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

ORCID-Profile: Nooshafarin Shirani, Hajar Yaghoobi

Förderung

  • Shahrekord University of Medical Sciences

Zitieren

APA

Shirani, N., Mahdi-Esferizi, R., Eshraghi Samani, R., Tahmasebian, S., & Yaghoobi, H. (2024). In silico identification and in vitro evaluation of MRPS30‐DT lncRNA and MRPS30 gene expression in breast cancer. Cancer Reports. https://doi.org/10.1002/cnr2.2114

Vancouver

Shirani N, Mahdi-Esferizi R, Eshraghi Samani R, Tahmasebian S, Yaghoobi H. In silico identification and in vitro evaluation of MRPS30‐DT lncRNA and MRPS30 gene expression in breast cancer. Cancer Reports. 2024. doi:10.1002/cnr2.2114

BibTeX
@article{Shirani2024,
  author = {Shirani, Nooshafarin and Mahdi-Esferizi, Roohallah and Eshraghi Samani, Reza and Tahmasebian, Shahram and Yaghoobi, Hajar},
  title = {In silico identification and in vitro evaluation of MRPS30‐DT lncRNA and MRPS30 gene expression in breast cancer},
  journal = {Cancer Reports},
  year = {2024},
  doi = {10.1002/cnr2.2114}
}
Kostenlos starten →